On my way CU tomorrow 🙋‍♂️

🚨 ESTRO Board Elections – Reminder! Voting opens soon (20 March–20 April)! If you wish to vote for the new Clinical and Physics representatives, you must be an ESTRO member in both 2024 & 2025. ⌛ Renew your 2025 membership by 10 March to be eligible to vote, only 1 week left!

Multidisciplinarity is key in diagnosis and treatment of thoracic malignancies #BTOG25 is leading the way, congrats to Sanjay Popat and all UK colleagues !

EORTC launches first European TwiCs within OligoCare randomising single vs multifraction SBRT for oligomets! Matthias Guckenberger

Innovation in RadOnc is strong HOWEVER, regulatory processes for clinical trials have become prohibitively complex & costly Innovative & collaborative research as SPRINT using TwiCs methodology by the ESTRO & EORTC are testing new ways to generate evidence

Health Business International conference in Paris Change of perspective on health care, financial models and opportunities for collaboration between academic public, and private sectors

#ELCC25 in Paris has started with ESTRO being a partner of the meeting Such multidisciplinary meetings are THE place to learn from our neighboring disciplines & teach them about the value of Radiation Oncology Tomorrow: borderline resectable stage III NSCLC, hot topic

This Wednesday 👇

SANO trial: non-surgical approach & organ preservation in pts esophageal cancer and complete clinical response after neoadjuvant RCT Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virt… Wednesday May 7th 17:00 – 17:30 - Safe the date ! Berend van der Wilk

🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna! 📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall 👉 Full interview here: bit.ly/4ifJd75 #Radonc #OncologyInnovation #ESTROAwards

🎉We’re excited to announce that the first patient has been randomised in the SPRINT study! The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad. 👉 project.eortc.org/e2-radiate/202… #E2RADIatE #OligoCare Piet Ost Matthias Guckenberger

📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from University of Toronto for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! Laura Dawson #lcsm

Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer “What if radiation oncology was a start up” Highlights the 5’s: Collaborate Communicate Learn from every Customer Cost Efficiency Culture

SBRT + 💊 in oligomets: 🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 EORTC ESTRO Ciro Franzese

🎥 Exclusive interview this morning at #ESTRO25: We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology. Don’t miss his insights ⬇️ #Radiotherapy #CancerResearch Matthias Guckenberger

Greetings from #ESTRO25 and a wam welcome to #APCCC26 in Lugano 🇨🇭 silke gillessen prof. Barbara Jereczek-Fossa Piet Ost Thomas Zilli Giulio Francolini Matthias Guckenberger Vedang Murthy OncoAlert 🚨

Join us for #ESTRO26 in Stockholm!!!

Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !